HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

In this episode we discuss the recent FDA approval of esketamine (Spravato) for the management of treatment resistant depression as an add on to oral antidepressant therapy. The agent is novel though so, too, may be its adverse effect profile and logistics of administration.

Direct download: 096_-_esketamine.mp3
Category:general -- posted at: 6:00am EST